Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): A prospective multicenter diagnostic cohort study

Chia sẻ: ViJakarta2711 ViJakarta2711 | Ngày: | Loại File: PDF | Số trang:11

Thêm vào BST

Báo xấu

8
lượt xem 1
download

Download Vui lòng tải xuống để xem tài liệu đầy đủ

After neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer, high pathologically complete response (pCR) rates are being achieved especially in patients with squamous cell carcinoma (SCC). An active surveillance strategy has been proposed for SCC patients with clinically complete response (cCR) after nCRT

Chủ đề: